
New mRNA Vaccine Cuts Neuroblastoma Tumors 70% in Mice
Irish researchers have developed a groundbreaking mRNA vaccine that slashed neuroblastoma tumors by 70% in laboratory mice, offering fresh hope for a childhood cancer that kills 15% of young patients. The innovative treatment could be personalized for each child within weeks.








